Kewaunee Q4 sales up 28.4% to $49.7M; backlog record $173.9M; full year loss widens

KEWAUNEE SCIENTIFIC CORP /DE/

Q4 sales $49.7M (+28.4% YoY); pre-tax earnings $2.3M vs loss $0.95M; EBITDA $2.97M vs -$0.30M.
Diluted EPS -$0.13 vs -$1.08; net loss $0.36M includes $2.56M valuation allowance from sale-leaseback.
Full year sales $168.9M (+14.5%); net loss $6.1M vs $3.7M; diluted EPS -$2.20 vs -$1.33.
Backlog $173.9M, highest in company history; up from $114.5M a year ago.
Domestic segment Q4 net earnings $2.38M vs loss; International net income $1.02M vs $0.96M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.